PATENT CLAIM ANALYSIS

Application Number: 16235652
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-07
Patent Classification: ["540", "520000"]

Abstract:
Disclosed herein, in various embodiments, are compounds having dual activity as PARP1 and CDK inhibitors, and pharmaceutical compositions comprising the same. In some embodiments, the present disclosure provides for methods of treating diseases or conditions in a subject in need thereof, comprising administering one or more compounds disclosed herein. In some embodiment, the disease is cancer, including breast cancer.

Claim (Index 14):
The compound of  claim 13 , wherein L is C 6  aryl-C 1  alkyl which is substituted with 13-membered heteroaryl which having 2 nitrogen atoms and which is substituted with a halogen and oxo.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 98.0
- Lexical Diversity: 1.4375
- Patent Class: 540.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16230412', '14977011', '14413745', '13217132', '13079763']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7197368134805336
- 35 USC 102 Novelty (BERT): 0.5235046604151784
- Combined Prediction Score: 0.7001135981739981
- Mean Citation Score: 306.95854
- Max Citation Score: 319.27917
- Similarity Product: 234.62406453318

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test